Miguel Angel Tola Arribas

Miguel Angel Tola Arribas

Auto-generated profile, based on publicly available information

Miguel Angel Tola Arribas

Department of Neurology, Hospital Universitario Río Hortega, Valladolid, Spain

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 January 2018 in Entropy
Verified
Journal Article
Open access
PDF file
SRSaúl J. Ruiz-Gómez
Saúl J. Ruiz-Gómez
Carlos GómezCarlos Gómez
Carlos Gómez
JPJesus Poza
Jesus Poza
Gonzalo Gutiérrez-TobalGonzalo Gutiérrez-Tobal
Gonzalo Gutiérrez-Tobal
MTMiguel A. Tola-Arribas
Miguel A. Tola-Arribas
Roberto HorneroRoberto Hornero
Roberto Hornero
The discrimination of early Alzheimer’s disease (AD) and its prodromal form (i.e., mild cognitive impairment, MCI) from cognitively healthy control (HC) subjects is crucial since the treatment is more effective in the first stages of the dementia. The aim of our study is to evaluate the usefulness of a methodology based on electroencephalography (EEG) to detect AD and MCI. EEG rhythms were recorded from 37 AD patients, 37 MCI subjects and 37 HC subjects. Artifact-free trials were analyzed by means of several spectral and nonlinear features: relative power in the conventional frequency bands, median frequency, individual alpha frequency, spectral entropy, Lempel–Ziv complexity, central tendency measure, sample entropy, fuzzy entropy, and auto-mutual information. Relevance and redundancy analyses were also conducted through the fast correlation-based filter (FCBF) to derive an optimal set of them. The selected features were used to train three different models aimed at classifying the trials: linear discriminant analysis (LDA), quadratic discriminant analysis (QDA) and multi-layer perceptron artificial neural network (MLP). Afterwards, each subject was automatically allocated in a particular group by applying a trial-based majority vote procedure. After feature extraction, the FCBF method selected the optimal set of features: individual alpha frequency, relative power at delta frequency band, and sample entropy. Using the aforementioned set of features, MLP showed the highest diagnostic performance in determining whether a subject is not healthy (sensitivity of 82.35% and positive predictive value of 84.85% for HC vs. all classification task) and whether a subject does not suffer from AD (specificity of 79.41% and negative predictive value of 84.38% for AD vs. all comparison). Our findings suggest that our methodology can help physicians to discriminate AD, MCI and HC.

8 June 2021 in Neurology
Verified
Journal Article
Closed access
PDF file
RNRaul G. Nogueira
Raul G. Nogueira
MQMuhammad M. Qureshi
Muhammad M. Qureshi
MAMohamad Abdalkader
Mohamad Abdalkader
SMSheila Ouriques Martins
Sheila Ouriques Martins
HYHiroshi Yamagami
Hiroshi Yamagami
ORon behalf of the SVIN COVID-19 Global Stroke Registry
on behalf of the SVIN COVID-19 Global Stroke Registry
Objective To measure the global impact of COVID-19 pandemic on volumes of IV thrombolysis (IVT), IVT transfers, and stroke hospitalizations over 4 months at the height of the pandemic (March 1 to June 30, 2020) compared with 2 control 4-month periods. Methods We conducted a cross-sectional, observational, retrospective study across 6 continents, 70 countries, and 457 stroke centers. Diagnoses were identified by their ICD-10 codes or classifications in stroke databases. Results There were 91,373 stroke admissions in the 4 months immediately before compared to 80,894 admissions during the pandemic months, representing an 11.5% (95% confidence interval [CI] −11.7 to −11.3, p < 0.0001) decline. There were 13,334 IVT therapies in the 4 months preceding compared to 11,570 procedures during the pandemic, representing a 13.2% (95% CI −13.8 to −12.7, p < 0.0001) drop. Interfacility IVT transfers decreased from 1,337 to 1,178, or an 11.9% decrease (95% CI −13.7 to −10.3, p = 0.001). Recovery of stroke hospitalization volume (9.5%, 95% CI 9.2–9.8, p < 0.0001) was noted over the 2 later (May, June) vs the 2 earlier (March, April) pandemic months. There was a 1.48% stroke rate across 119,967 COVID-19 hospitalizations. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection was noted in 3.3% (1,722/52,026) of all stroke admissions. Conclusions The COVID-19 pandemic was associated with a global decline in the volume of stroke hospitalizations, IVT, and interfacility IVT transfers. Primary stroke centers and centers with higher COVID-19 inpatient volumes experienced steeper declines. Recovery of stroke hospitalization was noted in the later pandemic months.

17 September 2019 in Journal of Neural Engineering
Verified
Journal Article
Closed access
PDF file
PNPablo Núñez
Pablo Núñez
JPJesus Poza
Jesus Poza
Carlos GómezCarlos Gómez
Carlos Gómez
VRVictor Rodriguez
Victor Rodriguez
AHArjan Hillebrand
Arjan Hillebrand
Roberto HorneroRoberto Hornero
Roberto Hornero
Objective . The characterization of brain functional connectivity is a helpful tool in the study of the neuronal substrates and mechanisms that are altered in Alzheimer’s disease (AD) and mild cognitive impairment (MCI). Recently, there has been a shift towards the characterization of dynamic functional connectivity (dFC), discarding the assumption of connectivity stationarity during the resting-state. The majority of these studies have been performed with functional magnetic resonance imaging recordings, with only a small subset being based on magnetoencephalography/electroencephalography (MEG/EEG). However, only these modalities enable the characterization of potentially fast brain dynamics, which is mandatory for an accurate understanding of the transmission and processing of neuronal information. The aim of this study was to characterize the dFC of resting-state EEG activity in AD and MCI. Approach . Three measures: the phase lag index (PLI), leakage-corrected magnitude squared coherence (MSCOH) and leakage-corrected amplitude envelope correlation (AEC) were computed for 45 patients with dementia due to AD, 51 subjects with MCI due to AD and 36 cognitively healthy controls. All measures were estimated in epochs of 60 s using a sliding window approach. An epoch length of 15 s was used to provide reliable results. We tested whether the observed PLI, MSCOH and AEC fluctuations reflected actual variations in functional connectivity, as well as whether between-group differences could be found. Main results . We found dFC using PLI, MSCOH and AEC, with AEC having the highest number of statistically significant connections, followed by MSCOH and PLI. Furthermore, a significant reduction in AEC dFC for patients with AD compared to controls was found in the alpha (8–13 Hz) and beta-1 (13–30 Hz) bands. Significance . Our results suggest that patients with AD (and MCI subjects to a lesser degree) show less variation in neuronal connectivity during resting-state, supporting the notion that dFC can be found at the EEG time scale and is abnormal in the MCI-AD continuum. Measures of dFC have the potential of being used as biomarkers of AD. Moreover, they could also suggest that AD resting-state networks may operate at a state of low firing activity induced by the observed reduction in coupling strength. Furthermore, the statistically significant correlation between dFC and relative power in the beta-1 band could be related to pathologically high levels of neural activity inducing a loss of dFC. These findings show that the stability of neuronal coupling is affected in AD and MCI.

17 October 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MTMiguel Angel Tola-Arribas
Miguel Angel Tola-Arribas
MYMaría Isabel Yugueros
María Isabel Yugueros
MGMaría José Garea
María José Garea
FOFernando Ortega-Valín
Fernando Ortega-Valín
ACAna Cerón-Fernández
Ana Cerón-Fernández
BDBárbara Díaz-Gómez
Bárbara Díaz-Gómez
To describe the prevalence of dementia and subtypes in a general elderly population in northwestern Spain and to analyze the influence of socio-demographic factors. Cross-sectional, two-phase, door-to-door, population-based study. A total of 870 individuals from a rural region and 2,119 individuals from an urban region of Valladolid, Spain, were involved. The seven-minute screen neurocognitive battery was used in the screening phase. A control group was included. A total of 2,170 individuals aged 65 to 104 years (57% women) were assessed. There were 184 subjects diagnosed with dementia. The crude prevalence was 8.5% (95% CI: 7.3-9.7). Age- and sex-adjusted prevalence was 5.5 (95% CI: 4.5-6.5). Main subtypes of dementia were: Alzheimer’s disease (AD) 77.7%, Lewy Body disease, 7.6% and vascular dementia (VD) 5.9%. Crude prevalences were 6.6% (AD), 0.6% (Lewy Body disease), and 0.5% (VD). Dementia was associated with age (OR 1.14 for 1-year increase in age), female sex (OR 1.79) and the absence of formal education (OR 2.53 compared to subjects with primary education or more). The prevalence of dementia in the study population was lower than the most recent estimates for Western Europe. There was a high proportion of AD among all dementia cases and very low prevalence of VD. Old age, female sex, and low education level were independent risk factors for dementia and AD.

30 October 2018 in Frontiers in Neuroinformatics
Verified
Journal Article
Open access
SRSaúl J. Ruiz-Gómez
Saúl J. Ruiz-Gómez
Carlos GómezCarlos Gómez
Carlos Gómez
JPJesus Poza
Jesus Poza
MMMario Martínez-Zarzuela
Mario Martínez-Zarzuela
MTMiguel A. Tola-Arribas
Miguel A. Tola-Arribas
Roberto HorneroRoberto Hornero
Roberto Hornero
Alzheimer’s Disease (AD) represents the most prevalent form of dementia and is considered a major health problem due to its high prevalence and its economic costs. An accurate characterization of the underlying neural dynamics in AD is crucial in order to adopt effective treatments. In this regard, mild cognitive impairment (MCI) is an important clinical entity, since it is a risk-state for developing dementia. In the present study, coupling patterns of 111 resting-state electroencephalography (EEG) recordings were analyzed. Specifically, we computed Cross-Approximate Entropy (Cross-ApEn) and Cross-Sample Entropy (Cross-SampEn) of 37 patients with dementia due to AD, 37 subjects with MCI and 37 healthy control (HC) subjects. Our results showed that Cross-SampEn outperformed Cross-ApEn, revealing higher number of significant connections among the three groups (Kruskal-Wallis test, FDR-corrected p-values < 0.05). AD patients exhibited statically significant lower dissimilarity values at alpha and beta1 frequency bands compared to HC. MCI is also characterized by a global decrease of dissimilarity in all bands, being only significant at beta1. These differences shows that beta band might play a significant role in the identification of early stages of AD. Clinically, the brain alterations and neural mechanisms involved in cognitive decline may be explained by the loss of acetylcholine, long-distance association fibers or gray matter volume. Our results suggest that Cross-SampEn could increase the insight into brain dynamics at different AD stages. Consequently, it may contribute to develop early AD biomarkers, potentially useful as diagnostic information.

22 August 2017 in Current Alzheimer Research
Verified
Journal Article
Closed access
PDF file
JPJesus Poza
Jesus Poza
Carlos GómezCarlos Gómez
Carlos Gómez
MGMaría García
María García
MTMiguel A. Tola-Arribas
Miguel A. Tola-Arribas
ACAlicia Carreres
Alicia Carreres
Roberto HorneroRoberto Hornero
Roberto Hornero
Background: An accurate characterization of neural dynamics in mild cognitive impairment (MCI) is of paramount importance to gain further insights into the underlying neural mechanisms in Alzheimer’s disease (AD). Nevertheless, there has been relatively little research on brain dynamics in prodromal AD. As a consequence, its neural substrates remain unclear. Methods: In the present research, electroencephalographic (EEG) recordings from patients with dementia due to AD, subjects with MCI due to AD and healthy controls (HC) were analyzed using relative power (RP) in conventional EEG frequency bands and a novel parameter useful to explore the spatio-temporal fluctuations of neural dynamics: the spectral flux (SF). Results: Our results suggest that dementia due to AD is associated with a significant slowing of EEG activity and several significant alterations in spectral fluctuations at low (i.e. theta) and high (i.e. beta and gamma) frequency bands compared to HC (p < 0.05). Furthermore, subjects with MCI due to AD exhibited a specific frequency-dependent pattern of spatio-temporal abnormalities, which can help identify neural mechanisms involved in cognitive impairment preceding AD. Classification analyses using linear discriminant analysis with a leave-one-out cross-validation procedure showed that the combination of RP and within-electrode SF at the beta band was useful to obtain a 77.3 % of accuracy to discriminate between HC and AD patients. In the case of comparison between HC and MCI subjects, the classification accuracy reached a value of 79.2 %, combining within-electrode SF at beta and gamma bands. SF has proven to be a useful measure to obtain an original description of brain dynamics at different stages of AD. Conclusion: Consequently, SF may contribute to gain a more comprehensive understanding into neural substrates underlying MCI, as well as to develop potential early AD biomarkers.